- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Idenix Pharmaceuticals Inc+ Add to Watchlist
IDIX:US5.1200 USD 0.1900 3.85%
As of 17:20:00 ET on 12/09/2013.
Company Profile for Idenix Pharmaceuticals Inc (IDIX)
Idenix Pharmaceuticals Inc. is a biopharmaceutical company that discovers and develops drugs for the treatment of human viral and other infectious diseases. The Company is focusing on the treatment of infections caused by hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV).
Idenix Pharmaceuticals Inc
Key Executives for Idenix Pharmaceuticals Inc (IDIX)
|Ronald C Renaud Jr "Ron"President/CEO||Douglas MayersExec VP/Chief Medical Officer|
|Daniella BeckmanSenior VP/CFO/Treasurer||Maria D StahlSenior VP/Secy/General Counsel|
|Paul J FanningSenior VP:Human Resources|